News

What’s At Stake As U.S. Supreme Court Considers Tariff Case

1 Mins read

The fate of U.S. President Donald Trump’s tariffs now lies in the hands of the U.S. Supreme Court. Trump is asking the court to overturn a lower court ruling that most of his administration’s tariffs exceeded the president’s authority. Chris Krueger, Managing Director at TD Cowen Washington Research Group, discusses the different scenarios and the implications for Trump’s trade agenda.

Transcript

Kim Parlee: The fate of US President Donald Trump’s tariffs now likely lies in the hands of the US Supreme Court. Trump is asking the court to overturn a lower court ruling that most of his tariffs imposed on countries like Canada are illegal. A lot at stake, including potentially having to pay billions in refunds.

Chris Krueger, Managing Director at TD Cowen Washington Research Group, has just come out with a report on what the next steps might be.

Chris, how are you?

Chris Krueger: I’m well. Great to be back with you, Kim.

Kim Parlee: Nice to have you back. I like to check in to see how you are, because you’re in the business of following every move, and I worry about you, Chris. I want to make sure you’re OK. [LAUGHS]

Chris Krueger: That’s very kind, Kim. Thank you.

Kim Parlee: Let’s talk about the tariffs. So, a lower court has said these are illegal. And now we go through the process to get it through to the Supreme Court. What are the possible scenarios that could come out of this? What are you looking at?

Chris Krueger: Yeah. Well, so the International Court said that IEEPA tariffs were illegal. The appellate court, in a 7-4 decision, upheld that. So, we’re now waiting for the Supreme Court to weigh in. Supreme Court is 9 justices. It breaks down 6-3 in terms of Republican to Democratic appointees.

Read the full article here

Related posts
News

HTD: Tax-Advantaged Monthly Income From Dividends (NYSE:HTD)

1 Mins read
This article was written by Follow David A. Johnson is founder and principal of Endurance Capital Management, a New Jersey Limited Liability…
News

Jasper Therapeutics, Inc. (JSPR) Discusses Investigation Into BEACON Study Anomalies and Preliminary ETESIAN Asthma Data - Slideshow (NASDAQ:JSPR) 2025-12-04

1 Mins read
This article was written by Follow Seeking Alpha’s transcripts team is responsible for the development of all of our transcript-related projects. We…
News

Qiagen N.V. (QGEN) Presents at Evercore 8th Annual Healthcare Conference Transcript

1 Mins read
Follow Play Earnings CallPlay Earnings Call Qiagen N.V. (QGEN) Evercore 8th Annual Healthcare Conference December 3, 2025 10:50 AM EST Company Participants…
Get The Latest News

Subscribe to get the top fintech and
finance news and updates.

Leave a Reply

Your email address will not be published. Required fields are marked *